Gilead, ‘closely attuned to’ potential US policy shifts, stands by long-acting PrEP launch
Lenacapavir, Pre-Exposure Prophylaxis, United States Food and Drug Administration, launch, HIV prevention, long-acting, U.S., Gilead
Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects
Reindeer, CAR-T, Staff, Neoplasms, Cell Therapy, Allogeneic CRISPR-edited Anti-CD19 CAR-T Cells CB-010, Clustered Regularly Interspaced Short Palindromic Repeats, Leukemia, Myelocytic, Acute, United States Food and Drug Administration, 32%
Merck KGaA closes in on SpringWorks deal at $3.5B price point
SpringWorks, Acquisition (action), KGaA, Infrequent, Gomekli, deal, Merck
Compounding pharmacies dealt a blow in fight over end of semaglutide shortage
United States Food and Drug Administration, semaglutide, Compound, enforcement, Pharmacy facility, shortage, Wegovy
Thermo Fisher jumps on the US investment bandwagon with $2B in additional spending
United States, Investments, Manufacture, Martes pennanti, Science, development aspects, Thermo Fisher
Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through
Merck, Legal patent, Subcutaneous Keytruda, Halozyme
FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns
Vyne, United States Food and Drug Administration, Testiculo-, Toxicity aspects, Study on Hold, United States Food and Drug Administration
Guided by data, Mosaic licenses two cancer compounds from Astex
Astex, Spatial Mosaic, ASTX029, MDM2 Antagonist ASTX295
Ex-FDA leader joins new initiative designed to fight ‘unfortunate reality’ of vaccine landscape
Vaccines, Project, Misinformation, Initiative, Policy, Intact, Ex-FDA, threat, Recommendation, M.D., reality
Sanofi’s Altuviiio closing in on blockbuster status, Dupixent sales surge
Altuviiio, Sales – occupational activity, sanofi, Dupixent, United States Food and Drug Administration